Crossmark

World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal

Crossref DOI link: https://doi.org/10.1186/s12985-018-1032-5

Published Online: 2018-08-06

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Diarra, Birama

Yonli, Albert Theophane

Ouattara, Abdoul Karim https://orcid.org/0000-0002-9767-0646
Zohoncon, Theodora Mahoukèdè

Traore, Lassina

Nadembega, Christelle

Obiri-Yeboah, Dorcas

Yara, Justine

Pietra, Virginio

Ouedraogo, Paul

Bougouma, Alain

Sanogo, Rokia

Simpore, Jacques
License Information

Text and Data Mining valid from 2018-08-06
More Information

Article History

Received: 23 March 2018

Accepted: 26 July 2018

First Online: 6 August 2018

Ethics approval and consent to participate

: Approval for the study was obtained from the National Health Ethic Committee (N° 2015–01-006). All study participants gave their free written and informed consent.

: Not Applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.